Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Low vitamin D levels are linked to increased risk of male pattern baldness.

PCOS requires personalized treatment to improve life quality and reduce health risks.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Long-term diabetes is linked to lower prostate cancer risk.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Boosting mitochondrial energy production with supplements like acetyl-L-carnitine may improve aging-related cellular function and health conditions.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.